Concepts in psoriasis: Psoriasis and the extracellular matrix

British Journal of Dermatology

Volumn 167, Issue 5, 2012, Pages 980-986

  McFadden, J ^a   Fry, L ^b   Powles, A V ^c   Kimber, I ^d  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b Faculty of Medicine   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA6BETA4 INTEGRIN; BACTERIAL TOXIN; CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; LAMININ; NEUTRALIZING ANTIBODY; STREPTOKINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 5;

BASEMENT MEMBRANE; CELL PROLIFERATION; DISEASE COURSE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GUTTATE PSORIASIS; HUMAN; HUMORAL IMMUNITY; INNATE IMMUNITY; KERATINOCYTE; MEMBRANE DAMAGE; NONHUMAN; PATHOPHYSIOLOGY; PLASMINOGEN ACTIVATION; POST STREPTOCOCCAL GUTTATE PSORIASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; REVIEW; STREPTOCOCCAL PHARYNGITIS; TH1 CELL; TH17 CELL; WOUND;

EXTRACELLULAR MATRIX; FIBRONECTINS; HUMANS; INTEGRIN ALPHA5BETA1; KERATINOCYTES; MODELS, BIOLOGICAL; PLASMINOGEN; PSORIASIS; STREPTOKINASE;

EID: 84868202979     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11149.x     Document Type: Review

References (65)

1. Christophers E, Kiene P,. Guttate and plaque psoriasis. Dermatol Clin 1995; 13: 751-6.
2. Fry L, Baker BS,. Triggering psoriasis: the role of infections and medications. Clin Dermatol 2007; 25: 606-15.
3. Telfer NR, Chalmers RJ, Whale K, Colman G,. The role of streptococcal infection in the initiation of acute guttate psoriasis. Arch Dermatol 1992; 128: 39-42.
4. Martin BA, Chalmers RJ, Telfer NJ,. How great is the risk of further psoriasis following a single episode of acute guttate psoriasis? Arch Dermatol 1996; 132: 717-18.
5. Williams RC, McKenzie AW, Roger JH, Joysey VC,. HL-A antigens in patients with guttate psoriasis. Br J Dermatol 1976; 95: 163-7.
6. Griffiths CEM,. Barker JNWN Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-71.
7. Mallon E, Bunce M, Savoie H, et al. HLA-C and guttate psoriasis. Br J Dermatol 2000; 143: 1177-82.
8. Fry L, Powles A, Corcoran S, et al. HLACw 06 is not essential for streptococcal-induced psoriasis. Br J Dermatol 2006; 154: 850-3.
9. Friedmann PS,. The immunology of allergic contact dermatitis: the DNCB story. Adv Dermatol 1990; 5: 175-95.
10. Dawe SA, White IR, Rycroft RJ, et al. Active sensitization to para-phenylenediamine and its relevance: a 10 year review. Contact Dermatitis 2004; 51: 96-7.
11. Diluvio J, Vollmer S, Besgen P, et al. Identical TCRβ-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris. J Immunol 2006; 176: 7104-11.
12. Leung DYM, Gately A, Trumble B, et al. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen (CLA). J Exp Med 1995; 181: 2225-31.
13. McFadden JP, Baker BS, Powles AV, Fry L,. Psoriasis and streptococci: the natural selection of psoriasis revisited. Br J Dermatol 2009; 160: 929-37.
14. McFadden JP, Baker BS, Powles AV, Fry L,. Psoriasis and extra domain A fibronectin loops. Br J Dermatol 2010; 163: 5-11.
15. Barker JN, Mitra RS, Griffiths CEM, et al. Keratinocytes as initiators of inflammation. Lancet 1991; 337: 211-14.
16. Tsan MF, Gao B,. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004; 76: 514-19.
17. Leon CG, Tory R, Jia J, et al. Discovery and development of Toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharm Res 2008; 25: 1751-61.
18. Rifkin IR, Leadbetter EA, Busconi L, et al. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 2005; 204: 27-42.
19. Dennehy KM, Willment JA, Williams DL, Brown GD,. Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur J Immunol 2009; 39: 1379-86.
20. Zhang SY, Jouanguy E, Sancho-Shimuzu V, et al. Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol Rev 2007; 220: 225-36.
21. Uematsu S, Akira S,. Toll-like receptors and type 1 interferons. J Biol Chem 2007; 282: 15319-23.
22. Nestle FO, Conrad C, Tun-Kyi A, et al. Defining upstream elements of psoriasis pathogenesis: an emerging role for interferon alpha. J Exp Med 2005; 202: 135-43.
23. Kaisho T, Akira S,. Regulation of dendritic cell function through toll-like receptors. Curr Mol Med 2003; 3: 375-85.
24. Sandig H, McDonald J, Gilmour J, et al. Fibronectin is a Th1-specific molecule in human subjects. J Allergy Clin Immunol 2009; 124: 528-35.
25. McFadden JP, Basketter DA, Dearman RJ, Kimber I,. Extra domain A-positive feedback loops and their association with cutaneous inflammatory disease. Clin Dermatol 2011; 29: 257-65.
26. Baker BS, Bokth S, Powles A, et al. Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions. Br J Dermatol 1993; 128: 493-9.
27. Chang JC, Smith LR, Froning KJ, et al. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor Vβ3 and/or Vβ 13.1 genes. Proc Natl Acad Sci USA 1994; 91: 9282-6.
28. Matsumura S, Wang B, Kawashima N, et al. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol 2008; 181: 3099-107.
29. Oh S, Schramme A, Tilgen W, et al. Overexpression of CXCL16 in lesional psoriatic skin. Dermatoendocrinol 2009; 1: 114-18.
30. Patel DN, Bailey SR, Gresham JK, et al. TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells. Biochem Biophys Res Commun 2006; 347: 1113-20.
31. Gunther C, Carballido-Perrig N, Kaesler S, et al. CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD4+ T cells. J Invest Dermatol 2012; 132: 626-34.
32. Weisenseel P, Prinz JC,. Incidental detection of S. pyogenes-DNA in psoriatic skin by PCR. Arch Dermatol Res 2005; 296: 573-6.
33. Nitsche-Schmitz DP, Rohde M, Chhatwal S,. Invasion mechanisms of Gram-positive cocci. Thromb Haemost 2007; 98: 488-96.
34. Baker BS, Laman JD, Powles A, et al. Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions. J Pathol 2006; 209: 174-81.
35. Baker BS, Ovigne J-M, Fischetti VA, et al. Selective response of dermal Th1 cells to 20-50 kDa streptococcal cell-wall proteins in chronic plaque psoriasis. Scand J Immunol 2003; 58: 335-41.
36. Ovigne JM, Baker BS, Davison SC, et al. Epidermal CD+ T cells reactive with group A streptococcal antigens in chronic plaque psoriasis. Exp Dermatol 2002; 11: 357-64.
37. Besgen P, Trommier P, Vollmer S, et al. Ezrin, maspin, peroxiredoxin 2, and heat shock protein 27: potential targets of a streptococcal-induced autoimmune response in psoriasis. J Immunol 2010; 184: 5392-402.
38. Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, et al. Streptococcal throat infections and exacerbations of chronic plaque psoriasis: a prospective study. Br J Dermatol 2003; 149: 530-4.
39. Owen CM, Chalmers RJ, O'Sullivan T, Griffiths CE,. A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. Br J Dermatol 2001; 145: 886-90.
40. Facinelli B, Spinaci C, Magi G, et al. Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 2001; 358: 30-3.
41. Kaplan EL, Chhatwal GS, Rohde M,. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis 2006; 43: 1398-406.
42. Rosenberg EW, Noah PW, Zanolli MD, et al. Use of rifampicin with penicillin and erythromycin in the treatment of psoriasis. Preliminary report. J Am Acad Dermatol 1986; 14: 761-4.
43. Tsankov N, Grozdev I,. Rifampicin-a mild immunosuppressive agent for psoriasis. J Dermatolog Treat 2011; 22: 62-4.
44. Mansood Q, Manzoor S, Rukhsana A,. Treatment of acute guttate psoriasis with rifampicin. Indian J Dermatol Venereol Leprol 2000; 66: 296-8.
45. Manson A, Adner M, Cardell IQ,. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir Res 2006; 7: 36-7.
46. Komorowska A, Komorowska J, Babasik M, et al. Cytokines locally produced from the hypertrophic nasopharyngeal and palatine tonsils. Int J Pediatr Otolaryngol 2005; 69: 937-41.
47. Ball SL, Siou GP, Wilson JA, et al. Expression and immunolocalisation of antimicrobial peptides within the human palatine tonsils. J Laryngol Otol 2007; 121: 973-8.
48. Wang B, Li S, Southern PJ, Cleary PP,. Streptococcal modulation of cellular invasion via TGF beta signalling. Proc Natl Acad Sci USA 2006; 103: 2380-5.
49. Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signalling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defence. J Exp Med 2001; 194: 519-28.
50. D'Elios MM, Benagiano M, Della Bella C, Amedei A,. T-cell responses to bacterial agents. J Infect Dev Ctries 2011; 5: 640-5.
51. Bassukas ID, Gaitanis G, Hundeiker M,. Leprosy and the natural selection for psoriasis. Med Hypotheses 2012; 78: 183-90.
52. Schorey JS, Li Q, McCourt DW, et al. A Mycobacterium leprae gene encoding a fibronectin binding protein is used for efficient invasion of epithelial cells and Schwann cells. Infect Immun 1995; 63: 2652-7.
53. Bata-Csorgo Z, Cooper KD, Ting KM, et al. Fibronectin and α5 integrin regulate keratinocyte cell cycling. A mechanism for increased fibronectin production of T cell lymphokine-driven hyperproliferation in psoriasis. J Clin Invest 1998; 101: 1509-18.
54. Ting K, Rothaupt D, McCormack TS, et al. Overexpression of the oncofetal FN variant containing the EDA splice-in segment in the dermal-epidermal junction of psoriatic uninvolved skin. J Invest Dermatol 2000; 114: 706-11.
55. Falk-Marzillier J, Domanico SZ, Pelletier A, et al. Characterization of a tight molecular complex between integrin alpha 6 beta 4 and laminin-5 extracellular matrix. Biochem Biophys Res Commun 1998; 251: 49-55.
56. Leask A, Abraham DJ,. TGF-beat signalling and the fibrotic response. FASEB J 2004; 18: 816-27.
57. White ES, Baraille FE, Muro AF,. New insights into form and function of fibronectin splice variants. J Pathol 2008; 216: 1-14.
58. Chhatwal GS, McMillan DJ,. Uncovering the mysteries of invasive streptococcal diseases. Trends Mol Med 2005; 11: 152-5.
59. Osterlund A, Popa R, Nikkila T, et al. Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscopy 1997; 107: 640-7.
60. Osterlund A, Engstrand L,. An intracellular reservoir of Streptococcus pyogenes in human tonsillar epithelium-studies of asymptomatic carriers and in vitro cultured biopsies. Acta Otolaryngol 1997; 117: 883-8.
61. Jensen PJ, Baird J, Belin D, et al. Tissue plasminogen activator in psoriasis. J Invest Dermatol 1990; 95: 13-14.
62. Li Q, Ke F, Zhang W, et al. Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice. PLoS ONE 2011 6: e16483, 1-10.
63. Blyth CC, Robertson PW,. Anti-streptococcal antibodies in the diagnosis of acute and post-streptococcal disease: streptokinase versus streptolysin O and deoxyribonuclease B. Pathology 2006; 38: 152-6.
64. Vaccaro M, Magaudda L, Cutroneo G, et al. Changes in the distribution of laminin alpha 1 chain in psoriasis skin: immunohistochemical study using confocal laser scanning microscopy. Br J Dermatol 2002; 146: 392-8.
65. Mondello MR, Magaudda L, Pergolizzi S, et al. Behaviour of laminin 1 and type IV collagen in uninvolved psoriatic skin. Immunohistochemical study using confocal laser scanning microscopy. Arch Dermatol Res 1996; 288: 527-31.